Teva Invites the Public to Listen to Its 2012 Investor Meeting Webcast
JERUSALEM -- December 06, 2012
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) invites investors and the
general public to listen to a live audio webcast of its 2012 Investor Meeting
on Tuesday, December 11, 2012 at 12:00 p.m. ET.
What: Teva’s 2012 Investor Meeting
Who: Teva Management
When: Tuesday, December 11, 2012 at 12:00 p.m. ET
Live over the Internet -- log on to the Web at the address above
How: and register for the event (approx. 10 minutes before). An archive
of the webcast will be available on Teva's website.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global
pharmaceutical company, committed to increasing access to high-quality
healthcare by developing, producing and marketing affordable generic drugs as
well as innovative and specialty pharmaceuticals and active pharmaceutical
ingredients. Headquartered in Israel, Teva is the world's leading generic drug
maker, with a global product portfolio of more than 1,300 molecules and a
direct presence in about 60 countries. Teva's branded businesses focus on CNS,
oncology, pain, respiratory and women's health therapeutic areas as well as
biologics. Teva currently employs approximately 46,000 people around the world
and reached $18.3 billion in net revenues in 2011.
Kevin C. Mannix
972 (3) 926-7656
972 (3) 926-7687
Press spacebar to pause and continue. Press esc to stop.